Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03281538 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
288
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cara Therapeutics, Inc.